| Clarification received from the company on news article |
The Exchange, in order to verify certain news articles appearing in the various newspapers/ websites/ television channels and also to inform the members / investors with regard to the accuracy of the news articles, had sought clarification from the following company. Reply received from them is attached.
1. Aurobindo Pharma Ltd (Scrip Code: 524804): www.business-standard.com
For & On behalf of BSE Ltd
|
Yogendra Daxini
|
Jeevan Noronha
|
|
Assistant General Manager
|
Senior Manager
|
|
Surveillance
|
Surveillance
|
06th December, 2018
|